{
    "organizations": [],
    "uuid": "f89bc0167e31e1c3eb59d472047d765b1e171b32",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zhejiang-jolly-pharmaceutical-sees/brief-zhejiang-jolly-pharmaceutical-sees-fy-2017-net-profit-down-20-pct-to-40-pct-idUSL4N1PL1L3",
    "ord_in_thread": 0,
    "title": "BRIEF-Zhejiang Jolly Pharmaceutical sees FY 2017 net profit down 20 pct to 40 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 26(Reuters) - Zhejiang Jolly Pharmaceutical Co Ltd\n* Sees FY 2017 net profit to decrease by 20 percent to 40 percent, or to be 43.2 million yuan to 57.6 million yuan\n* Says FY 2016 net profit was 72 million yuan\n* Says decreased gross margin of core business is the main reason for the forecast\nSource text in Chinese: goo.gl/Do4DPy\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-26T10:26:00.000+02:00",
    "crawled": "2018-01-26T21:06:47.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "zhejiang",
        "jolly",
        "pharmaceutical",
        "co",
        "ltd",
        "see",
        "fy",
        "net",
        "profit",
        "decrease",
        "percent",
        "percent",
        "million",
        "yuan",
        "million",
        "yuan",
        "say",
        "fy",
        "net",
        "profit",
        "million",
        "yuan",
        "say",
        "decreased",
        "gross",
        "margin",
        "core",
        "business",
        "main",
        "reason",
        "forecast",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}